A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.

Zisis TsourisChristos LiaskosEfthymios DardiotisThomas ScheperVana TsimourtouWolfgang MeyerGeorge HadjigeorgiouDimitrios P Bogdanos

Published in: Auto- immunity highlights (2020)

Despite the relatively frequent presence of liver autoantibodies, tested either by IF or molecular assays, overt AILD is rather infrequent discouraging autoantibody screening strategies of MS patients in the absence of clinical suspicion.

Keyphrases

end stage renal disease
systemic lupus erythematosus
multiple sclerosis
ejection fraction
newly diagnosed
chronic kidney disease
mass spectrometry
ms ms
prognostic factors
drug induced